“Yale Cancer Center researchers have defined the genetic characteristics of ovarian tumors, information that could lead to new opportunities for personalized therapy,… View more
“A team led by Andrew Godwin, PhD, deputy director of The University of Kansas Cancer Center and director of molecular oncology in… View more
“Studies show that early detection is vital to cancer survival, but diagnosing can be invasive and even dangerous in the earlier stages… View more
This new study reports the complexity of molecular landscape in the very early phase of ovarian cancer development, before ovarian cancer arises…. View more
A donor has gifted $5 million to the Division of Gynecologic Oncology in the Susan F. Smith Center for Women’s Cancers at… View more
An exciting new technology is being developed for a smartphone device to detect the BRCA1 gene mutation (which can put an individual… View more
